SWOG clinical trial number
S9703

Phase II Trial of Antibiotic Eradication of Helicobacter Pylori and, Failing That, Systemic Chemotherapy with CHOP and Local Therapy with Involved Field Radiation in Patients with Malt Lymphomas

Closed
Phase
Accrual
0%
Abbreviated Title
Antibiotic eradication of H. pylori and, if needed, CHOP + RT
Activated
09/15/1997
Closed
03/01/1999
Participants
NCORP, Members, Medical Oncologists, Radiation Oncologists, Pathologists

Research committees

Lymphoma

Treatment

Radiation Therapy clarithromycin metronidazole omeprazole tetracycline CHOP RT

Eligibility Criteria Expand/Collapse

Biopsy proven gastric or duodenal mucosa-associated lymphoma tissue (MALT) non-Hodgkin's lymphoma; Stage IE or IIE1; neg. BM biopsy; neg. chest x-ray or scan; positive for H. pylori; no prior chemo or RT for lymphoma; no AIDS or HIV.

Other Clinical Trials

SWOG Clinical Trial Number
S2207

Randomized Phase II Study of the Addition of Targeted Therapeutic Agents to Tafasitamab-Based Therapy in Non-Transplant-Eligible Patients with Relapse/Refractory Large B-Cell Lymphoma
Research Committee(s)
Lymphoma
Activated
06/30/2023
Accrual
7%
Open
Phase
SWOG Clinical Trial Number
CTSU/AHOD2131

A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma
Research Committee(s)
Lymphoma
Immunomolecular Therapeutics
Activated
04/28/2023
Open
Phase
SWOG Clinical Trial Number
S2114

A Randomized Phase II trial of consolidation therapy following CD19 CAR T-cell treatment for Relapsed/Refractory Diffuse Large B-cell Lymphoma or Grade IIIB Follicular Lymphoma
Research Committee(s)
Lymphoma
Activated
02/23/2023
Accrual
15%
Open
Phase